Advancing HIV drug resistance testing: A leap forward with DNA-based genotyping

Yan Jiang

doi:10.1016/j.jpha.2026.101636

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2026 > Accepted Manu

Yan Jiang. Advancing HIV drug resistance testing: A leap forward with DNA-based genotyping[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2026.101636

Citation:

Yan Jiang. Advancing HIV drug resistance testing: A leap forward with DNA-based genotyping[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2026.101636

Yan Jiang. Advancing HIV drug resistance testing: A leap forward with DNA-based genotyping[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2026.101636

Citation:

Yan Jiang. Advancing HIV drug resistance testing: A leap forward with DNA-based genotyping[J]. Journal of Pharmaceutical Analysis. doi: 10.1016/j.jpha.2026.101636

PDF( 440 KB)

Advancing HIV drug resistance testing: A leap forward with DNA-based genotyping

doi: 10.1016/j.jpha.2026.101636

Yan Jiang^,

National Center for AIDS/STD Control and Prevention, China CDC, Beijing, China

Available Online: Apr. 17, 2026

Abstract

FullText(HTML)

References(3)

References

[1]	J. Hao, X. Liu, D. Wang, et al., Transmitted HIV-1 drug resistance among newly diagnosed individuals in 31 provincial-level administrative divisions in China in 2023: A cross-sectional survey, Clin. Infect. Dis. 81 (2025) 531-538.
[2]	C. Wu, L. Zhang, Z. Chen, et al., Large-scale evaluation of HIV-1 DNA drug resistance testing as a robust tool for clinical decision-making: A nationwide study in China, J. Pharm. Anal. 16 (2026), 101513.
[3]	B. Cao, M. Liu, S. Song, et al., HIV-1 DNA genotypic drug resistance testing guides antiretroviral therapy in patients with low-level viremia, AIDS Res. Hum. Retroviruses 41 (2025) 197-202.